STOCK TITAN

Iveda Solutions SEC Filings

IVDA NASDAQ

Welcome to our dedicated page for Iveda Solutions SEC filings (Ticker: IVDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Iveda Solutions, Inc. filings document the company's public-company reporting as a Delaware corporation focused on AI video surveillance, smart city technologies, and IoT platforms. Registration statements and amendments describe securities offerings, capital structure, operating and financial results, and risk disclosures tied to the company's technology business.

Current reports cover material events including Nasdaq continued-listing notices, stockholders' equity compliance, minimum bid-price matters, and registered securities consisting of common stock and common stock purchase warrants. Proxy materials document annual meeting matters such as director elections, auditor ratification, shareholder voting mechanics, and governance procedures.

Rhea-AI Summary

Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Iveda Solutions reporting persons Lind Global Fund III LP, Lind Global Partners III LLC and Jeff Easton disclose beneficial ownership of 1,158,920 shares, representing 9.99% of common stock as of 02/11/2026. The holdings consist of 857,143 shares of common stock and 1,714,286 warrants, but conversion of the warrants is contractually limited so the aggregate beneficial ownership has been capped at 1,158,920 shares.

The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power for the partnership's shares and that Jeff Easton, as managing member, may be deemed to have sole voting and dispositive power. The filing includes a joint filing agreement and is signed on 02/19/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Iveda Solutions, Inc. received a Schedule 13G reporting a significant but non-controlling position by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC. As of the close of business on February 13, 2026, they may be deemed to beneficially own 592,195 shares of common stock issuable upon exercise of a warrant, representing about 4.99% of the outstanding common stock.

The filing explains that additional shares underlying several Intracoastal warrants are blocked from exercise if doing so would push ownership above limits of 4.99% or 9.99%. The reporting persons certify the securities were not acquired to change or influence control of Iveda.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Iveda Solutions, Inc. completed a public offering of 5,714,286 shares of common stock (or pre-funded warrants in lieu) and Series X warrants to purchase up to 11,428,572 shares at a combined price of $0.35. The transaction generated approximately $2 million in gross proceeds before fees and expenses. The company issued additional placement agent warrants and paid cash fees to H.C. Wainwright & Co. and plans to use the net proceeds for general corporate purposes, including potential R&D, debt repayment, working capital, capital spending, acquisitions, joint ventures, and stock repurchase programs. The offering was conducted under an effective Form S-1 registration statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Iveda Solutions, Inc. received an institutional ownership filing showing that entities affiliated with Iroquois Capital report meaningful positions in its common stock. Iroquois Capital Management LLC reports beneficial ownership of 500,000 shares, representing 4.5% of the common stock, with shared voting and dispositive power over these shares.

Richard Abbe reports beneficial ownership of 714,286 shares, or 6.4% of the class, combining 214,286 shares over which he has sole voting and dispositive power with 500,000 shares over which he shares authority. Kimberly Page reports beneficial ownership of 500,000 shares, or 4.5%, with shared voting and dispositive power.

The filing notes additional warrants held by related entities that are exercisable for up to 1,000,000 and 428,572 shares for certain funds, and 1,428,572 shares for Mr. Abbe, but these are currently blocked by 4.99% Beneficial Ownership Blockers. Based on a prospectus indicating 11,139,740 shares outstanding as of the completion of a recent offering, the reported percentages reflect these blockers. The reporting persons certify that the securities are not held for the purpose of changing or influencing control of Iveda Solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Iveda Solutions, Inc. is conducting a primary offering of 5,259,999 shares of common stock and pre-funded warrants to purchase up to 454,287 shares, together with 5,714,286 Series X Warrants to buy up to 11,428,572 shares, plus 400,000 placement agent warrants. The common stock and Series X Warrants are priced at $0.35 per share-and-warrant unit, with pre-funded units priced at $0.3499, for total gross proceeds of $1,999,971 and estimated net proceeds of $1,859,971 before expenses. Each Series X Warrant is exercisable immediately at $0.35 per share for two years, and each pre-funded warrant is exercisable at $0.0001 per share until fully exercised. Common shares outstanding are expected to increase from 5,879,741 to 11,139,740 after the stock issuance, excluding warrant exercises. The company plans to use proceeds for general corporate purposes, including software R&D, working capital, debt repayment, capital spending, acquisitions and other corporate initiatives, while warning of significant risks including going concern doubts, continued losses, customer concentration, Taiwan exposure and potential Nasdaq delisting if listing standards are not maintained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.64%
Tags
prospectus
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.64%
Tags
other
-
Rhea-AI Summary

Iveda Solutions, Inc. has filed an amended S-1 to offer up to 5,434,782 shares of common stock, together with up to 5,434,782 pre-funded warrants and up to 5,434,782 Series X warrants to buy up to 10,869,564 additional shares, on a reasonable best efforts basis. The assumed combined price is $0.92 per share and accompanying Series X warrants, matching the last Nasdaq Capital Market close on January 28, 2026.

The company, recently redomiciled to Delaware, develops AI-driven video analytics and IoT-based smart city platforms, with most revenue generated by its Taiwan subsidiary. It has a going concern opinion, accumulated losses of about $51 million through December 31, 2024, and relies heavily on a small number of key customers. There is no minimum offering amount or escrow, so investor funds become immediately available even if limited capital is raised, and the new securities will dilute existing holders, with common shares outstanding rising from 5,879,741 to 11,314,523 if all shares (but no warrants) are sold.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Rhea-AI Summary

Iveda Solutions, Inc. is conducting a reasonable best efforts primary offering of up to 5,434,782 shares of common stock at an assumed combined price of $0.92 per share together with Series X warrants to purchase up to 10,869,564 additional shares. The company may instead issue up to 5,434,782 pre-funded warrants in lieu of common stock for investors constrained by 4.99% or 9.99% ownership limits, with each pre-funded warrant exercisable at $0.0001 per share.

The Series X warrants are exercisable upon issuance at $0.92 per share and expire two years after issuance. Common stock outstanding was 5,879,741 shares before the offering and is expected to be 11,314,523 shares after the offering, excluding existing options and warrants. Iveda highlights significant risks, including a going concern opinion, accumulated losses of roughly $51–53 million, heavy reliance on its Taiwan subsidiary for most revenue, customer concentration, and the possibility of Nasdaq delisting if listing standards are not maintained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

How many Iveda Solutions (IVDA) SEC filings are available on StockTitan?

StockTitan tracks 28 SEC filings for Iveda Solutions (IVDA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Iveda Solutions (IVDA)?

The most recent SEC filing for Iveda Solutions (IVDA) was filed on February 25, 2026.